An International Observational Study of Adults With Acute Infection

NCT07069400 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2026-04-02

No results posted yet for this study

Summary

Prospective, longitudinal studies of people with acute infections are essential to understand risk factors, clinical manifestations, pathobiology, and management strategies. Observational studies can provide data necessary to select interventions and strategies for testing in clinical trials and to develop key design features of trials. Observational studies can be particularly important for establishing an early knowledge base after emergence of a new pathogen, as illustrated by the recent emergence of influenza A (H1N1), SARS-CoV-2, and Mpox. This observational study protocol describes collection of data and biospecimens from sites across the world for characterizing acute infections in hospitalized patients. The protocol is designed to study respiratory infections, infections outside the respiratory tract, established infectious diseases, and emerging infectious diseases. Data generated in this study will be used to efficiently characterize acute infectious diseases and plan future clinical trials.

Conditions

Interventions

OTHER

No intervention

This is an observational study

Sponsors & Collaborators

Principal Investigators

  • Cavan Reilly, PhD · University of Minnesota

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-25
Primary Completion
2027-06-08
Completion
2027-06-08

Countries

  • United States
  • Argentina
  • Australia
  • Brazil
  • Côte d’Ivoire
  • Denmark
  • France
  • Germany
  • Greece
  • Japan
  • Singapore
  • South Korea
  • Spain
  • Thailand
  • Uganda
  • Ukraine
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07069400 on ClinicalTrials.gov